Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Integra Lifesciences Holdings Corp (IART) USD0.01

Sell:$71.90 Buy:$71.91 Change: $0.28 (0.39%)
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
Change: $0.28 (0.39%)
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
Change: $0.28 (0.39%)
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Integra LifeSciences Holdings Corporation provides regenerative technologies and neurosurgical solutions. The Company offers a portfolio of brands including AmnioExcel, Bactiseal, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, SurgiMend, TCC-EZ, and VersaTru. The Company offers solutions in orthopedics, neurosurgery, and reconstructive and general surgery. The Company operates through two segments: Codman Specialty Surgical segment, and Orthopedics and Tissue Technologies segment. The Codman Specialty Surgical segment includes the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care. The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.

Contact details

United States
+1 (609) 2750500

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$6.10 billion
Shares in issue:
84.58 million
Health Care Equipment
United States
US dollar

Key personnel

  • Stuart Essig
    Independent Chairman of the Board
  • Peter Arduini
    President, Chief Executive Officer, Director
  • Carrie Anderson
    Chief Financial Officer, Executive Vice President
  • Glenn Coleman
    Chief Operating Officer, Executive Vice President
  • Lisa Evoli
    Executive Vice President, Chief Human Resources Officer
  • Eric Schwartz
    Executive Vice President, Chief Legal Officer, Secretary
  • Robert Davis
    Executive Vice President, President - Tissue Technologies
  • Michael Mcbreen
    Executive Vice President and President - Codman Specialty Surgical
  • Jeffrey Mosebrook
    Senior Vice President, Principal Accounting Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.